icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018		 Back grey_arrow_rt.gif
 
 
 
Real-life effectiveness and safety of velpatasvir/sofosbuvir/voxilaprevir for previously DAA treated patients with chronic hepatitis C
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
 

1113181

1113182

1113183